期刊文献+

气管支气管淀粉样变1例报道及临床分析

One Case Report of Tracheobronchial Amyloidosis and Clinical Analysis
下载PDF
导出
摘要 目的从病因、临床症状和体征、诊断和治疗等方面结合目前国内外的最新进展对呼吸系统淀粉样变进行探讨。方法我们诊治了1例临床少见病例。为58岁的老年妇女在6年前被诊断患有乳腺癌,后来继发出现了气管支气管淀粉样变,我们对其进行了马法兰和强的松联合化疗。结果这种联合治疗方案诱导了慢反应,并使疾病得到了部分的缓解。结论淀粉样变是一种罕见疾病,为一种特殊的蛋白质进展性地沉积在间质纤维,影响器官功能,甚至导致死亡。只要有可能,临床上就应当对患者进行试验性的治疗,如单纯化疗、高剂量的化疗联合外周血干细胞移植或低剂量的体外放疗。 Objective To discuss the respiratory tract amyloidosis through integrating the latest development at home and abroad horn the etiology,Presenting Symptoms and Signs,diagnosis and treatment areas. Methods We remedy a rare case of a 58-year-old female patient who was diagnosed with breast cancer 6 years ago and subsequently presented with tracheobronchial amyloidosis. Then the female patient was treated with a melphalan and prednisone regimen. Results This combination induced slow responses and led to partial remission of the disease. Conclusion Amyloidosis is a group of rare diseases in which a specific protein is deposited as aggregated interstitial fibrils that can compromise organ function and lead to death. Whenever possible,patients should be treated on clinical trials such as Chemotherapy alone, high-dose chemotherapy with peripheral blood stem cell transplant or low dose external beam radiation therapy.
作者 王健宇
出处 《中国现代医生》 2008年第23期68-69,71,共3页 China Modern Doctor
关键词 支气管 淀粉样变 治疗 Bronchus Amyloidosis Therapy
  • 相关文献

参考文献8

  • 1[1]Merlini G,Bellotti V.Molecular mechanisms of amyloidosis[J].New England Journal of Medicine,2003,349(6):583-596.
  • 2[2]Tong J,Turbat-Henrrera EA,Herrera GA.Role of translational research advancing the understanding of the pathogenesis of light chain-mediated glomerulopathies[J].Pathology International,2007,57(7):398-412.
  • 3[4]Utz JP,Swensen SJ,MA.Pulmonary amyloidosis.The Mayo Clinic experience from 1980 to 1993[J].Annals of Internal Medicine,1996,124(4):407-413.
  • 4[5]Kyle RA,Gertz MA,Greipp PR,et al.A trial of three regirnens for primary amyloidosis:colchicine alone,melphalan and prednisone,and melphalan,prednisone,and colchicine[see comments][J].New England Journal of Medicine,1997,336(17):1202-1207.
  • 5[6]perfetti V,Siena S,Palladini G,et al.Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary(AL)amyloidosis[J].Haematologica,2006,91(12):1635-1643.
  • 6[7]Wechalekar AD,Goodman HI,Lachmaan HJ,et al.Safety and efficacy of risk-adapted cyclophosphamide,thalidomide,and dexamethasone in systemic AL amyloidosis[J].Blood,2007,109(2):457-464.
  • 7[8]Wechalekar A,Gillmore J,Lachmann H,et al.Efficacy and safety of bortezomib in systemic AL amyloidosus-apreliminary report[J].ASH Ann Meet Abstr,2006,108(10):129.
  • 8[9]Truong M,Kacnic LA,Grillone GA.The Role of Radiation Therapy for Progressive Airway Amyloidosis[J].International Journal of Rsdiation Oncology*Biology*Physics,2007,69(2):122.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部